Literature DB >> 19861919

MET receptor tyrosine kinase.

Leonardo Faoro1, Gustavo M Cervantes, Essam El-Hashani, Ravi Salgia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19861919      PMCID： PMC2846396          DOI： 10.1097/01.JTO.0000361752.86918.09

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  10 in total

1.  Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.

Authors:  L Schmidt; F M Duh; F Chen; T Kishida; G Glenn; P Choyke; S W Scherer; Z Zhuang; I Lubensky; M Dean; R Allikmets; A Chidambaram; U R Bergerheim; J T Feltis; C Casadevall; A Zamarron; M Bernues; S Richard; C J Lips; M M Walther; L C Tsui; L Geil; M L Orcutt; T Stackhouse; J Lipan; L Slife; H Brauch; J Decker; G Niehans; M D Hughson; H Moch; S Storkel; M I Lerman; W M Linehan; B Zbar
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

2.  Molecular cloning of a new transforming gene from a chemically transformed human cell line.

Authors:  C S Cooper; M Park; D G Blair; M A Tainsky; K Huebner; C M Croce; G F Vande Woude
Journal:  Nature       Date:  1984 Sep 6-11       Impact factor: 49.962

3.  Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Authors:  Patrick C Ma; Ramasamy Jagadeeswaran; Simha Jagadeesh; Maria S Tretiakova; Vidya Nallasura; Edward A Fox; Mark Hansen; Erik Schaefer; Katsuhiko Naoki; Alan Lader; William Richards; David Sugarbaker; Aliya N Husain; James G Christensen; Ravi Salgia
Journal:  Cancer Res       Date:  2005-02-15       Impact factor: 12.701

4.  c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.

Authors:  Patrick C Ma; Takashi Kijima; Gautam Maulik; Edward A Fox; Martin Sattler; James D Griffin; Bruce E Johnson; Ravi Salgia
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

Review 5.  c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.

Authors:  Martin Sattler; Ravi Salgia
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

6.  Expression and mutational analysis of MET in human solid cancers.

Authors:  Patrick C Ma; Maria S Tretiakova; Alexander C MacKinnon; Nithya Ramnath; Candace Johnson; Sascha Dietrich; Tanguy Seiwert; James G Christensen; Ramasamy Jagadeeswaran; Thomas Krausz; Everett E Vokes; Aliya N Husain; Ravi Salgia
Journal:  Genes Chromosomes Cancer       Date:  2008-12       Impact factor: 5.006

7.  The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

Authors:  Tanguy Y Seiwert; Ramasamy Jagadeeswaran; Leonardo Faoro; Varalakshmi Janamanchi; Vidya Nallasura; Mohamed El Dinali; Soheil Yala; Rajani Kanteti; Ezra E W Cohen; Mark W Lingen; Leslie Martin; Soundararajan Krishnaswamy; Andres Klein-Szanto; James G Christensen; Everett E Vokes; Ravi Salgia
Journal:  Cancer Res       Date:  2009-03-24       Impact factor: 12.701

8.  A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.

Authors:  Neelu Puri; Andrey Khramtsov; Salman Ahmed; Vidya Nallasura; Jeremy T Hetzel; Ramasamy Jagadeeswaran; Greg Karczmar; Ravi Salgia
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

9.  Increased MET gene copy number negatively affects survival of surgically resected non-small-cell lung cancer patients.

Authors:  Federico Cappuzzo; Antonio Marchetti; Margaret Skokan; Elisa Rossi; Sujatha Gajapathy; Lara Felicioni; Maela Del Grammastro; Maria Grazia Sciarrotta; Fiamma Buttitta; Matteo Incarbone; Luca Toschi; Giovanna Finocchiaro; Annarita Destro; Luigi Terracciano; Massimo Roncalli; Marco Alloisio; Armando Santoro; Marileila Varella-Garcia
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

10.  Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.

Authors:  P C Ma; M S Tretiakova; V Nallasura; R Jagadeeswaran; A N Husain; R Salgia
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640
  10 in total
  4 in total

Review 1.  Molecular testing in lung cancer: the time is now.

Authors:  Haiying Cheng; Xunhai Xu; Daniel B Costa; Charles A Powell; Balazs Halmos
Journal:  Curr Oncol Rep       Date:  2010-09       Impact factor: 5.075

2.  Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies.

Authors:  Tayebeh Mehdipour; Mohammad R Tohidkia; Amir Ata Saei; Amir Kazemi; Shirin Khajeh; Ali A Rahim Rahimi; Sepideh Nikfarjam; Mehrdad Farhadi; Monireh Halimi; Ramin Soleimani; Roman A Zubarev; Mohammad Nouri
Journal:  Immunology       Date:  2019-11-08       Impact factor: 7.397

3.  CircTMTC1 contributes to nasopharyngeal carcinoma progression through targeting miR-495-MET-eIF4G1 translational regulation axis.

Authors:  Yajie Zhao; Chao Li; Yan Zhang; Zhanzhan Li
Journal:  Cell Death Dis       Date:  2022-03-18       Impact factor: 9.685

4.  Interaction Analysis of Adenovirus L5 Protein With Pancreatic Cancer Cell Surface Receptor to Analyze Its Affinity for Oncolytic Virus Therapy.

Authors:  Maryum Nisar; Rehan Zafar Paracha; Alvina Gul; Iqra Arshad; Saima Ejaz; Didar Murad; Shahzeb Khan; Zartasha Mustansar
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.